- cafead   Feb 28, 2024 at 11:12: AM
via U.S. drugmaker Eli Lilly (LLY.N), opens new tab expects to launch Mounjaro, its blockbuster diabetes drug and wildly popular obesity treatment, in India as early as next year after it clears an ongoing regulatory review, CEO David Ricks told Reuters on Wednesday.
article source
article source